Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Wright Medical Group, Inc. Acquires the Foot and Ankle Product Line of A.M. Surgical, Inc.

Wright Medical Group, Inc. a global orthopaedic medical device company, announced that it has acquired certain assets of A.M. Surgical, Inc.,company focused on providing endoscopic soft tissue release products for foot and ankle surgeons. Wright has been marketing A.M. Surgical's foot and ankle products.

Exercises enhances life of Breast Cancer survivors after treatment

A study of more than 500 breast cancer survivors shows that itโ€™s never too late to reap the benefits of an exercise program. The study, found that breast cancer survivors who pursued physical activity during and after treatment reported an improved quality of life, including less fatigue and pain.

GE Healthcare gets top ranking in Bone mineral densitometry customer satisfaction

Bone mineral densitometry equipment, MD Buyline, an independent medical technology and informatics intelligence firm in its latest report, has ranked GE Healthcare number one for the second consecutive quarter.

A New Concept in Annuloplasty for Valve Repair: the Biodegradable Ring

Medtronic plc announced U.S. FDA approval of the Evolut Transcatheter Aortic Valve Replacement (TAVR) system
The Kalangosยฎ ring was developed for pediatric annuloplasty to preserveย  the growth potential of the child’s heart. It is also suitable for adult annuloplasty by extension. This now commercially available device made ofย  biodegradable polydioxanone induces the growth of autologous fibrousย  tissue that reinforces the deficient annulus.

Companies to focus on their service centers to strengthen customer support and provide easier access

The Healthcare industry is one of the largest industries catering to the medical needs of innumerable people around the globe.ย  Consuming over 10 percent of the gross domestic product of most developed nations, healthcare is an enormous part of a countryโ€™s economy.

A New Approach to Managing GORD

Until now, assessing the progress of treatment for Gastro-Oesaphageal Refluxย  Disease (GORD) has relied primarily on an assessment of oesophageal healing. Documenting GORD therapy success is a difficult task, as mucosal damage doesย  not always correspond with the severity of symptoms.1 In addition, 70% of allย  patients with GORD symptoms have endoscopic-negative GORD.2,3

Bone Substitutes to Replace Transplantation?

Q BioMed Launches Non-Opioid Treatment for Metastatic Bone Pain
An osteoconductive and osteoinductive biphasic ceramic replacement forย  bone loss could be an alternative to grafts. The safety and efficacy of thisย  material has been shown in preclinical and clinical trials, demonstrating itsย  suitability.

Catheter Ablation Increases A-Fib Recoveries

Research continues into new ways of preventing and curing A-Fib, boostedย  by ever-increasing new technologies. Catheter ablation has become aย  mainstream treatment for the disease due to greaterย ย ย ย  technologicalย  accuracy. It is widely recognised that the impact of Atrial Fibrillation (A-Fib) is not only responsible for significant cardiovascular and cerebrovascular morbidity and mortality, but is also placing severe strain on healthcare resources.

Eliminating Latent TB

Latent TB in healthcare workers is a major threat to patients. Traditionalย  tests have too often beenย  unable to detect the condition reliably. A newย  blood test looks set to change this, which is good news for patients – andย  healthcare workers.

Cowen analysts – Rotation in health-care stocks

DataRobot and InterSystems Partner to Accelerate Adoption of AI in Healthcare
Bracing for a rocky 2008, investors in health-care stocks are increasingly moving their cash out of “one-hit” wonder drug developers and into companies with broader-based product portfolios, according to analysts at Cowen and Co.
Translate ยป